The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Wednesday broker round-up UPDATE

Wed, 21st May 2014 08:36

African Minerals: Citi reduces target price from 260p to 190p, while leaving its buy recommendation unchanged.Alliance Pharma: Numis lowers target price from 39p to 37p and maintains an add rating.APR Energy: JP Morgan shifts target price from 1082p to 1089p keeping its overweight rating.AstraZeneca: UBS raises target price from 4825p to 5000p maintaining its buy recommendation.Babcock International: Berenberg cuts target price from 1540p to 1510p staying with its buy recommendation.Brown (N) Group: UBS reduces target price from 535p to 485p, while upgrading from sell to neutral.Centaur Media: Westhouse Securities lowers target price from 77p to 71p and keeps an add rating.Centamin: Investec shifts target price from 57p to 62p and stays with its hold recommendation.Conygar Investment Company: Liberum Capital lowers target price from 204p to 200p and retains a buy recommendation.Entertainment One: JP Morgan cuts target price from 356p to 323p, while reiterating its overweight rating.Finnaust Mining: Sanlam Securities initiates with a target price of 8p and a buy recommendation.Homeserve: JP Morgan raises target price from 295p to 323p keeping its neutral rating.Intermediate Capital Group: Numis reduces target price from 475p to 363p retaining a reduce rating.Lamprell: Liberum Capital shifts target price from 150p to 155p and maintains a hold recommendation.Marks & Spencer: Nomura takes target price from 520p to 560p and retains a buy recommendation. Citi reduces target price from 510p to 465p downgrading to neutral. Berenberg cuts target price from 415p to 395p and reiterates a hold recommendation.Morrison (Wm): Deutsche Bank lowers target price from 200p to 190p downgrading to sell.Novae Group: Numis moves target price from 575p to 585p and retains a hold recommendation.Paragon Group: UBS ups target price from 350p to 374p and reiterates a neutral rating. Numis increases target price from 219p to 244p, but still recommends selling.Petroceltic: Westhouse Securities cuts target price from 275p to 250p and retains a buy recommendation.RM: Numis takes target price from 165p to 178p reiterating a buy recommendation.RSA Insurance: Citi ups target price from 480p to 501p maintaining a neutral rating.Vectura: Investec places its target price (prev.: 170p) under review, while leaving its buy recommendation unaltered.Victrex: JP Morgan shifts target price from 1704p to 1710p and stays with its neutral rating.Wolf Minerals: Investec lowers target price from 28p to 23p and retains a buy recommendation.

Related Shares

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...

3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out...

2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...

2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood canc...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.